Gain of 5p15.33 is associated with progression of bladder cancer

Oncology

Volumn 72, Issue 1-2, 2007, Pages 132-138

  Yamamoto, Yoshiaki ^a   Chochi, Yasuyo ^a   Matsuyama, Hideyasu ^a   Eguchi, Satoshi ^a   Kawauchi, Shigeto ^a   Furuya, Tomoko ^a   Oga, Atsunori ^a   Kang, Jason J ^b   Naito, Katsusuke ^a   Sasaki, Kohsuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Macrogen Inc   (South Korea)

Author keywords

5p15.33; Bladder cancer; TPPP; ZDHHC11

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BLADDER CANCER; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 5; DISEASE PROGRESSION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; RISK ASSESSMENT; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 37049019661     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111132     Document Type: Article

References (27)

1. Ross JS, Cohen MB: Ancillary methods for the detection of recurrent urothelial neoplasia. Cancer 2000;90:75-86.
2. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821.
3. Bruch J, Wohr G, Hautmann R, Mattfeldt T, Bruderlein S, Moller P, Sauter S, Hameister H, Vogel W, Paiss T: Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q. Genes Chromosomes Cancer 1998;23:167-174.
4. Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, Mihatsch MJ, Sauter G: Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 1998;153:1615-1621.
5. Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G: Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 1999;59:4658-4661.
6. Ueno T, Tangoku A, Yoshino S, Abe T, Toshimitsu H, Furuya T, Kawauchi S, Oga A, Oka M, Sasaki K: Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2002;8:526-533.
7. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997;20:399-407.
8. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-211.
9. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM: Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 2005;11:7012-7022.
10. Hlavanda E, Kovacs J, Olah J, Orosz F, Medzihradszky KF, Ovadi J: Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations. Biochemistry 2002;41:8657-8664.
11. Tirian L, Hlavanda E, Olah J, Horvath I, Orosz F, Szabo B, Kovacs J, Szabad J, Ovadi J: TPPP/p25 promotes tubulin assemblies and blocks mitotic spindle formation. Proc Natl Acad Sci USA 2003;100:13976-13981.
12. Lehotzky A, Tirian L, Tokesi N, Lenart P, Szabo B, Kovacs J, Ovadi J: Dynamic targeting of microtubules by TPPP/p25 affects cell survival. J Cell Sci 2004;117:6249-6259.
13. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG: American Joint Committee on Cancer;American Cancer Society. Testis;in: AJCC Cancer Staging Manual, ed 6. New York, Springer, 2002, pp 317-322.
14. Yamamoto Y, Matsuyama H, Furuya T, Oga A, Yoshihiro S, Okuda M, Kawauchi S, Sasaki K, Naito K: Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer. Clin Cancer Res 2004;10:6449-6455.
15. Yamamoto Y, Matsuyama H, Kawauchi S, Furuya T, Liu XP, Ikemoto K, Oga A, Naito K, Sasaki K: Biological characteristics in bladder cancer depend on the type of genetic instability. Clin Cancer Res 2006;12:2752-2758.
16. Yamamoto Y, Matsuyama H, Kawauchi S, Matsumoto H, Nagao K, Ohmi C, Sakano S, Furuya T, Oga A, Naito K, Sasaki K: Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer. Oncology 2006;70:231-237.
17. Matsuda K, Matsuyama H, Hara T, Yoshihiro S, Oga A, Kawauchi S, Furuya T, Izumi H, Naito K, Sasaki K: DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries. Cancer Genet Cytogenet 2004;152:119-123.
18. Cho YL, Bae S, Koo MS, Kim KM, Chun HJ, Kim CK, Ro DY, Kim JH, Lee CH, Kim YW, Ahn WS: Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol Oncol 2005;99:545-551.
19. Sasaki K, Kurose A, Miura Y, Sato T, Ikeda E: DNA ploidy analysis by laser scanning cytometry (LSC) in colorectal cancers and comparison with flow cytometry. Cytometry 1996;23:106-109.
20. Hiddemann W, Schumann J, Andreef M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA: Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet 1984;13:181-183.
21. Furuya T, Uchiyama T, Murakami T, Adachi A, Kawauchi S, Oga A, Hirano T, Sasaki K: Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Clin Cancer Res 2000;6:2815-2820.
22. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, Lafuente A, Wiencke JW, Terdiman JP, Waldman FM: High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 2004;25:1345-1357.
23. Zheng M, Simon R, Mirlacher M, Maurer R, Gasser T, Forster T, Diener PA, Mihatsch MJ, Sauter G, Schraml P: TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol 2004;165:63-69.
24. Shay JW, Wright WE: Implications of mapping the human telomerase gene (hTERT) as the most distal gene on chromosome 5p. Neoplasia 2000;2:195-196.
25. Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R, Vidaud M: Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000;6:452-459.
26. Komiya T, Kawase I, Nitta T, Yasumitsu T, Kikui M, Fukuoka M, Nakagawa K, Hirashima T: Prognostic significance of hTERT expression in non-small cell lung cancer. Int J Oncol 2000;16:1173-1177.
27. Orosz F, Kovacs GG, Lehotzky A, Olah J, Vincze O, Ovadi J: TPPP/p25: from unfolded protein to misfolding disease: prediction and experiments. Biol Cell 2004;96:701-711.